Nathan Hardy
2021
In 2021, Nathan Hardy earned a total compensation of $683.5K as Executive Vice President, Chief Financial Officer at Sana Biotechnology.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $170,000 |
| Salary | $413,493 |
| Total | $683,493 |
Hardy received $413.5K in salary, accounting for 60% of the total pay in 2021.
Hardy also received $100K in bonus and $170K in non-equity incentive plan.
Rankings
In 2021, Nathan Hardy's compensation ranked 9,969th out of 12,412 executives tracked by ExecPay. In other words, Hardy earned more than 19.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,969 out of 12,412 | 20th |
Division Manufacturing | 4,409 out of 5,498 | 20th |
Major group Chemicals And Allied Products | 1,959 out of 2,374 | 18th |
Industry group Drugs | 1,741 out of 2,095 | 17th |
Industry Biological Products, Except Diagnostic Substances | 379 out of 452 | 16th |
Source: SEC filing on April 26, 2022.
Hardy's colleagues
We found two more compensation records of executives who worked with Nathan Hardy at Sana Biotechnology in 2021.